CELL & GENE THERAPY INSIGHTS

Dec 2020. Vol 6 Issue 11

Dec 2020

FEATURING

Issue Spotlight: Tools of tomorrow
Focus: Purification
Report: Regulatory Insights December 2020

Other articles

Spotlight

Tools of tomorrow
Dec 2020

Innovator Insight

What to expect in 2021: seven cell and gene therapy commercialization trends

What to expect in 2021: seven cell and gene therapy commercialization trends
Heidi Hagen
10 December 2020
Innovator Insight
Read more

Commentary

Tools for tomorrow: expression without cells

Tools for tomorrow: expression without cells
Jade Tuck,
Stuart Jamieson,
Philip Probert
8 January 2021
Commentary
Read more

Interview

The engineer’s perspective: evolution in cell therapy bioprocess automation

The engineer’s perspective: evolution in cell therapy bioprocess automation
Brijender Parsad
23 December 2020
Interview
Read more
Redeploying biopharma process development and validation best practices for cell and gene therapy

Redeploying biopharma process development and validation best practices for cell and gene therapy
Suzanne Aldington
23 December 2020
Interview
Read more
An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS
Leszek Lisowski, PhD, MBA,
Wendy Gold
23 December 2020
Interview
Read more
Widening the reach of induced pluripotent stem cell-based therapy

Widening the reach of induced pluripotent stem cell-based therapy
Geoff Hamilton
16 December 2020
Interview
Read more

Podcast

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS
Leszek Lisowski, PhD, MBA,
Wendy Gold
22 December 2020
Podcast
Listen now

Expert Roundtable Video

Viral vector production process intensification: analytics, automation, in-line testing, and more

Viral vector production process intensification: analytics, automation, in-line testing, and more
Susan D’Costa,
Michael Delahaye,
Michael DiBiasio-White,
Franz Gerner,
Jessica Tate,
Jim Warren, Ph.D
18 January 2021
Expert Roundtable Video
Watch now

Expert Roundtable

Viral vector production process intensification: analytics, automation, in-line testing and more

Viral vector production process intensification: analytics, automation, in-line testing and more
Susan D’Costa,
Michael Delahaye,
Michael DiBiasio-White,
Franz Gerner,
Jessica Tate,
Jim Warren, Ph.D
9 February 2021
Expert Roundtable
Read more

Review

Detection of extracellular analytes via nanoscale optical sensors

Detection of extracellular analytes via nanoscale optical sensors
Ivon Acosta,
Abigail Haworth,
Becca Francis,
Nicole Iverson
5 January 2021
Review
Read more

Vectors FOCUS

Purification

Innovator Insight

Scalable AAV manufacturing: addressing challenges across the workflow

Scalable AAV manufacturing: addressing challenges across the workflow
18 January 2021
Innovator Insight
Read more

Interview

Empty/full separation: gene therapy’s hidden challenge

Empty/full separation: gene therapy’s hidden challenge
Mark Schofield
22 January 2021
Interview
Read more
Achieving optimal downstream bioprocessing for AAV vector

Achieving optimal downstream bioprocessing for AAV vector
Eric Gershenow
23 December 2020
Interview
Read more

Podcast

Empty/full separation: gene therapy’s hidden challenge

Empty/full separation: gene therapy’s hidden challenge
Mark Schofield
22 January 2021
Podcast
Listen now

Report

Regulatory Insights December 2020

Perspective

Exosomes as therapeutics and drug delivery vehicles: global regulatory perspectives

Exosomes as therapeutics and drug delivery vehicles: global regulatory perspectives
Shaun Stapleton
17 December 2020
Perspective
Read more

Interview

A year like no other: reflecting on the challenges of 2020, and looking to regain momentum for cell and gene therapy in 2021

A year like no other: reflecting on the challenges of 2020, and looking to regain momentum for cell and gene therapy in 2021
Peter Marks
8 January 2021
Interview
Read more

Other articles

FastFacts

Navigating cell therapy supply chain complexities during the COVID-19 pandemic

Navigating cell therapy supply chain complexities during the COVID-19 pandemic
Erin Rasch
16 December 2020
FastFacts
Read more